Company: RILYN
Filing Date: 2025-02-21
Form Type: 10-Q
Source: 0001628280-25-007082
Chunk: 447

Company: B. Riley Financial, Inc.
Filing Date: 2025-02-21
Form: 10-Q
Item: Part I, Item 8
Chunk 447
---
 by investing activities consisted of cash provided by loans receivable 

94

repayment of $105.3 million, sale of loans receivable of $22.8 million, and proceeds from sale of loan participations of $4.0 million, partially offset by cash used in purchases of loans receivable of $79.9 million, acquisition of businesses and minority interest, net of cash acquired of $19.1 million, purchases of property and equipment of $6.7 million, purchases of equity and other investments of $1.1 million, and sale of business, net of cash sold and other of $0.3 million. During the nine months ended September 30, 2023, cash provided by investing activities consisted of cash received from loans receivable repayment of $543.6 million, funds received from trust account of subsidiary of $175.8 million, proceeds from sale of business, net of cash sold and other of $17.3 million, and sale of loan receivable of $7.5 million, partially offset by cash used for purchases of loans receivable of $405.4 million, acquisition of businesses and minority interest of $15.3 million, purchases of equity and other investments of $4.9 million, and purchases of property and equipment of $5.8 million.

Cash used in financing activities was $354.7 million during the nine months ended September 30, 2024 compared to cash used in financing activities of $285.5 million during the nine months ended September 30, 2023. During the nine months ended September 30, 2024, cash used in financing activities primarily consisted of $140.5 million used to redeem senior notes, $94.2 million used in payment of revolving lines of credit, $138.6 million used in the repayment of term loan, $33.6 million used to pay dividends on our common shares, $6.2 million used to repay our notes payable and other, $6.0 million used to pay dividends on our preferred shares, $7.4 million used to pay contingent consideration, $4.6 million in distributions to noncontrolling interests, $3.5 million used to pay debt issuance and offering costs, and $3.1 million used in payment of ESPP and employment taxes on vesting of restricted stock, partially offset by cash provided by $64.1 million in proceeds from revolving line of credit, $15.0 million in proceeds from notes payable, $